Fallopian Tube Neoplasms Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Fallopian Tube Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 3

A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

Ovarian NeoplasmsNeoplasm MetastasisFallopian Tube Neoplasms+1 more
Eli Lilly and Company1,080 enrolled251 locationsNCT07213804
Recruiting
Not Applicable

OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy

High-grade Serous Ovarian Carcinoma (HGSOC)Fallopian Tube NeoplasmsOvarian Neoplasm Epithelial+1 more
Swiss GO Trial Group60 enrolled7 locationsNCT06466382
Recruiting
Phase 3

MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)

High-grade Serous Ovarian Carcinoma (HGSOC)Fallopian Tube NeoplasmsOvarian Neoplasm Epithelial+3 more
Swiss GO Trial Group540 enrolled53 locationsNCT04111978
Recruiting

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Ovarian NeoplasmsStage III Ovarian Cancer AJCC v8Stage IV Ovarian Cancer AJCC v8+12 more
Massachusetts General Hospital250 enrolled6 locationsNCT04794322
Recruiting
Phase 1

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

Endometrial CancerSolid TumorSolid Tumor, Adult+3 more
Bio-Path Holdings, Inc.50 enrolled4 locationsNCT04196257
Recruiting
Not Applicable

Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers

Fallopian Tube NeoplasmsCarcinoma, Ovarian EpithelialPeritoneal Neoplasms
Institut du Cancer de Montpellier - Val d'Aurelle300 enrolled1 locationNCT03976999
Recruiting
Not Applicable

MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm.

Ovarian CancerAdnexal CarcinomaOvarian Mass+4 more
Royal Surrey County Hospital NHS Foundation Trust40 enrolled1 locationNCT06638593